Pharmacogenomic Test that Predicts Response to Inhaled Corticosteroids in Adults with Asthma Likely to be Cost-Saving

References

• Israel E , BanerjeeTR , FitzmauriceGM , KotlovTV , LahiveK , LeboffMS . Effects of inhaled glucocorticoids on bone density in premenopausal women . N. Engl. J. Med.345 ( 13 ), 941 – 947 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Isaksson M . Skin reactions to inhaled corticosteroids . Drug Saf.24 ( 5 ), 369 – 373 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Jick SS , Vasilakis-ScaramozzaC , MaierWC . The risk of cataract among users of inhaled steroids . Epidemiology12 ( 2 ), 229 – 234 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Robinson DS , CampbellDA , DurhamSR , PfefferJ , BarnesPJ , ChungKF . Systematic assessment of difficult-to-treat asthma . Eur. Respir. J.22 ( 3 ), 478 – 483 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Strunk RC , SternbergAL , BacharierLB , SzeflerSJ . Nocturnal awakening caused by asthma in children with mild-to-moderate asthma in the childhood asthma management program . J. Allergy Clin. Immunol.110 ( 3 ), 395 – 403 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Chan MT , LeungDY , SzeflerSJ , SpahnJD . Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma . J. Allergy Clin. Immunol.101 ( 5 ), 594 – 601 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Drazen JM , SilvermanEK , LeeTH . Heterogeneity of therapeutic responses in asthma . Br. Med. Bull.56 ( 4 ), 1054 – 1070 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Szefler SJ , MartinRJ , KingTSet al. Significant variability in response to inhaled corticosteroids for persistent asthma . J. Allergy Clin. Immunol.109 ( 3 ), 410 – 418 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Sharek PJ , BergmanDA . The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis . Pediatrics106 ( 1 ), E8 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Patel L , WalesJK , KibirigeMS , MassaranoAA , CourielJM , ClaytonPE . Symptomatic adrenal insufficiency during inhaled corticosteroid treatment . Arch. Dis. Child.85 ( 4 ), 330 – 334 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Wu AC , HimesBE , Lasky-SuJet al. Development of a pharmacogenetic predictive test in asthma: proof of concept . Pharmacogenet. Genomics20 ( 2 ), 86 – 93 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Xu M , TantisiraKG , WuAet al. Genome wide association study to predict severe asthma exacerbations in children using random forests classifiers . BMC Med. Genet.12 , 90 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• McGeachie MJ , WuAC , ChangHH , LimaJJ , PetersSP , TantisiraKG . Predicting inhaled corticosteroid response in asthma with two associated SNPs . Pharmacogenomics J.13 ( 4 ), 306 – 311 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wu AC , HimesBE , TantisiraK , WeissST . Development of a pharmacogenetic test that predicts response to inhaled corticosteroids in asthma patients [Abstract 304] . Presented at : 59th Annual Meeting of The American Society of Human Genetics . Honolulu, Hawaii , 20–24 October 2009 .
   Google Scholar
• Phillips KA , VeenstraDL , RamseySD , Van BebberSL , SakowskiJ . Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs . Am. J. Manag. Care10 ( 7 Pt 1 ), 425 – 432 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Cost–Effectiveness in Health and Medicine. Gold MR , SiegelJE , RussellLB , WeinsteinMC ( Eds ). Oxford University Press , New York, USA ( 1996 ).
   Google Scholar
• Fuhlbrigge AL , BaeSJ , WeissST , KuntzKM , PaltielAD . Cost–effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density . J. Allergy Clin. Immunol.117 ( 2 ), 359 – 366 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Paltiel AD , FuhlbriggeAL , KitchBTet al. Cost–effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model . J. Allergy Clin. Immunol.108 ( 1 ), 39 – 46 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Wu AC , PaltielAD , KuntzKM , WeissST , FuhlbriggeAL . Cost–effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model . J. Allergy Clin. Immunol.120 ( 5 ), 1146 – 1152 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Expert Panel Report 3 (EPR-3). Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007 . J. Allergy Clin. Immunol.120 ( 5 Suppl. ), S94 – S138 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Thomson NC , ChaudhuriR , LivingstonE . Asthma and cigarette smoking . Eur. Respir. J.24 ( 5 ), 822 – 833 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Meltzer EO , LockeyRF , FriedmanBFet al. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma . Mayo Clin. Proc.77 ( 5 ), 437 – 445 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Pearlman DS , WhiteMV , LiebermanAKet al. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma . Ann. Allergy Asthma Immunol.88 ( 2 ), 227 – 235 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Bleecker ER , WelchMJ , WeinsteinSFet al. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma . J. Allergy Clin. Immunol.105 ( 6 Pt 1 ), 1123 – 1129 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Busse W , WolfeJ , StormsWet al. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial . J. Fam. Pract.50 ( 7 ), 595 – 602 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Nathan RA , MinkwitzMC , BonuccelliCM . Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness . Ann. Allergy Asthma Immunol.82 ( 5 ), 497 – 503 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Kim KT , GinchanskyEJ , FriedmanBFet al. Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy . Ann. Allergy Asthma Immunol.85 ( 5 ), 398 – 406 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Williams B , NoonanG , ReissTFet al. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older . Clin. Exp. Allergy31 ( 6 ), 845 – 854 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Krishnan JA , BenderBG , WamboldtFSet al. Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial . J. Allergy Clin. Immunol.129 ( 1 ), 112 – 118 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Mallal S , PhillipsE , CarosiGet al. HLA-B*5701 screening for hypersensitivity to abacavir . N. Engl. J. Med.358 ( 6 ), 568 – 579 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Drug Topics Red Book . Medical Economics Company , Montvale, NJ, USA ( 2009 ).
   Google Scholar
• Serra-Batlles J , PlazaV , MorejonE , ComellaA , BruguesJ . Costs of asthma according to the degree of severity . Eur. Respir. J.12 ( 6 ), 1322 – 1326 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Cisternas MG , BlancPD , YenIHet al. A comprehensive study of the direct and indirect costs of adult asthma . J. Allergy Clin. Immunol.111 ( 6 ), 1212 – 1218 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Stanford R , MclaughlinT , OkamotoLJ . The cost of asthma in the emergency department and hospital . Am. J. Respir. Crit. Care Med.160 ( 1 ), 211 – 215 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Lewis CE , RachelefskyG , LewisMA , De La SotaA , KaplanM . A randomized trial of A.C.T. (asthma care training) for kids . Pediatrics74 ( 4 ), 478 – 486 ( 1984 ).
   PubMed Web of Science ®Google Scholar
• Ross RN , MorrisM , SakowitzSR , BermanBA . Cost–effectiveness of including cromolyn sodium in the treatment program for asthma: a retrospective, record-based study . Clin. Ther.10 ( 2 ), 188 – 203 ( 1988 ).
   PubMed Web of Science ®Google Scholar
• Weiss KB , GergenPJ , HodgsonTA . An economic evaluation of asthma in the United States . N. Engl. J. Med.326 ( 13 ), 862 – 866 ( 1992 ).
   PubMed Web of Science ®Google Scholar
• Coventry JA , WestonMS , CollinsPM . Emergency room encounters of pediatric patients with asthma: cost comparisons with other treatment settings . J. Ambul. Care Manage.19 ( 2 ), 9 – 21 ( 1996 ).
   PubMedGoogle Scholar
• Segal R , RiedLD , MackowiakJ . Cost of asthma illnesses: emergency department visits without admission . Pharm. Pract. Manag. Q.15 ( 3 ), 72 – 82 ( 1995 ).
   PubMedGoogle Scholar
• Moy ML , FuhlbriggeAL , BlumenscheinKet al. Association between preference-based health-related quality of life and asthma severity . Ann. Allergy Asthma Immunol.92 ( 3 ), 329 – 334 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Wu AC , LiL , FungVet al. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids . J. Allergy Clin. Immunol. Pract.2 ( 5 ), 607 – 613 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• O’Brien BJ , GertsenK , WillanAR , FaulknerLA . Is there a kink in consumers’ threshold value for cost–effectiveness in health care?Health Econ.11 ( 2 ), 175 – 180 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Dowie J . Why cost–effectiveness should trump (clinical) effectiveness: the ethical economics of the South West quadrant . Health Econ.13 ( 5 ), 453 – 459 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Rand C , BilderbackA , SchillerK , EdelmanJM , HustadCM , ZeigerRS . Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial . J. Allergy Clin. Immunol.119 ( 4 ), 916 – 923 ( 2007 ).
   PubMed Web of Science ®Google Scholar